Evidence map›Paper›PMID 33179783›Full record

ArticleHepatology (Baltimore, Md.)2021

Doublecortin-Like Kinase Protein 1 in Cholangiocarcinoma: Is This the Biomarker and Target We Have Been Looking For?

Vik Meadows, Heather Francis

Open access · greenAbstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Hepatology (Baltimore, Md.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. DEB-TACE with irinotecanFrontiers in bioengineering and biotechnology · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Vik MeadowsRichard L. Roudebush VA Medical Center, Indiana University School of Medicine Research, Indianapolis, IN.
Heather FrancisRichard L. Roudebush VA Medical Center, Indiana University School of Medicine Research, Indianapolis, IN.
Indiana University School of MedicineRichard L. Roudebush VA Medical Center · US

Funding

The Paracrine Regulation of Mast Cells During Biliary/Cholangiocyte Repair and DamageR01DK108959 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI FRANCIS, HEATHER L · 2016 to 2024
$2.5M
Mechanisms of mast cell/cholangiocyte regulation of non-alcoholic fatty liver disease progressionR01DK119421 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI FRANCIS, HEATHER L · 2019 to 2022
$1.4M
Mechanisms of synergistic regulation of biliary inflammation and fibrosisI01BX003031 · VA · RLR VA MEDICAL CENTER · PI FRANCIS, HEATHER L · 2016 to 2023
–
BLRD VA I01 BX003031BLRD VA IK6 BX005226NIDDK NIH HHS DK108959NIDDK NIH HHS R01 DK108959NIDDK NIH HHS R01 DK119421NIH HHS DK119421
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bile Duct NeoplasmsCholangiocarcinomaBile Ducts, IntrahepaticBiomarkersDoublecortin Domain ProteinsDoublecortin-Like KinasesHumansIntracellular Signaling Peptides and ProteinsMicrotubule-Associated ProteinsNeuropeptidesProtein Serine-Threonine KinasesStem CellsBiomarkersDCLK1 protein, humanDoublecortin Domain ProteinsDoublecortin-Like KinasesIntracellular Signaling Peptides and ProteinsMicrotubule-Associated ProteinsNeuropeptidesProtein Serine-Threonine Kinases

Identifiers

PMID33179783
PMCPMC9274666
OpenAlexW3106182783

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.